NCT01515384View on ClinicalTrials.gov

A Trial of 18F-AV-133 Positron Emission Tomography (PET)

PHASE1TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DRUG

18F-AV-133

IV injection, 7.6 mCi (281.2 MBq)

Trial Locations (1)

10027

Research Site, New York

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY

NCT01515384 - A Trial of 18F-AV-133 Positron Emission Tomography (PET) | Biotech Hunter | Biotech Hunter